ReviewAging clinical and experimental research2026
Why acetylcholinesterase inhibitors should be considered disease-modifying drugs for Alzheimer's disease?
Giovanni Zuliani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it